Back close
Admissions

Dr. Rehna Rasheed

Assistant Professor, Department of Ophthalmology, School of Medicine, Kochi

Qualification: MBBS, MS(Ophthalmology), FRCOphth
rehnarasheed@aims.amrita.edu

Bio Publications Qualification Area of Expertise Experience Awards Roles
Bio

Dr. Rehna Rasheed is an accomplished ophthalmologist currently serving as Assistant Professor in Ophthalmology at Amrita Hospital, Kochi. She holds extensive experience in managing complex medical retina cases, uveitis, neuro-ophthalmology, and cataracts. Having pursued her Fellowship in Medical Retina and Ocular Inflammation at Bristol Eye Hospital in the UK, she has developed significant expertise in retinal disorders. Dr. Rehna has been actively involved in several international clinical trials and research initiatives, refining her skills and contributing to advancements in the field of ophthalmology. Her training and research work have cemented her reputation as an expert in the field of retinal disorders.

 

Publications

Journal Article

Year : 2020

Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in South India

Cite this Research Publication : Gopal S Pillai, Remadevi, Kiran Krishnankutty, Anilkumar, Rehna Rasheed, Greeshma Ravindran "Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in South India", Indian Journal Ophthalmol, 2020

Publisher : Indian Journal Ophthalmol,

Year : 2020

Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India.

Cite this Research Publication : G. S. Pillai, Remadevi Kiran Krishnankutty, Anilkumar V., Natasha Radhakrishnan, Rehna Rasheed, and Greeshma C. Ravindran, “Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India.”, Indian J Ophthalmol, vol. 68, no. 5, pp. 827-833, 2020.

Publisher : Indian J Ophthalmol

Qualification
  • MBBS: Medical College, Trichur, University of Calicut, India (2004)
  • Diploma in Ophthalmology: Regional Institute of Ophthalmology, Trivandrum, Kerala University, India (2009)
  • M.S. Ophthalmology: Regional Institute of Ophthalmology, Trivandrum, Kerala University, India (2010)
  • FRCOphth: Royal College of Ophthalmologists, London (2015)
Area of Expertise

• Vitreoretinal services
• Medical retina
• Uveitis and neuro-ophthalmology
• Cataract surgery (Phaco)
• Glaucoma
• Cornea and anterior segment

Experience

• Assistant Professor, Vitreoretinal Services, Amrita Hospital, Kochi (Present)
• Fellow in Medical Retina and Ocular Inflammation, Bristol Eye Hospital, United Kingdom (2016-2017)
• Registrar in Ophthalmology, James Cook University Hospital, Middlesbrough, United Kingdom (2011-2016)

Awards
  • Co-investigator for multiple international trials (HARRIER, SEQUOIA, SPECTRI, VICI, AXIS, and others)
  • Involved in recruiting patients and data collection for international research trials
  • Published research on rare ophthalmological conditions, endophthalmitis, and retinal disorders
  • Awarded Good Clinical Practice certifications (2016, 2021)
Roles

Sub-investigator for various international trials:

  • HARRIER: Phase III trial in wet AMD evaluating the efficacy of RTH 258 in comparison to Eylea.
  • SEQUOIA: Safety and efficacy of Abicipar peg in wet AMD.
  • SPECTRI: Study investigating the safety and efficacy of Lampalizumab in geographic atrophy.
  • DRAKO: A study to assess the effectiveness of Eylea in diabetic macular edema in routine clinical practice.
  • VICI: Study to evaluate the effect and safety of epleronone in CSR.
  • AXIS Study: A Phase 3, Randomised, Double-Blind, Parallel Group, Multicentre study to Compare Efficacy, Safety, Pharmacokinetics and Immunogenicity of BP05
  • Versus EU-Approved Lucentis in Patients with Wet Age-Related Macular Degeneration.
  • FOCUS Trial: Long-term Effects of Semaglutide on Diabetic Retinopathy in Subjects with Type 2 Diabetes.
  • LAMBDA Study: A double-masked, Parallel Group, Randomised, Multicentre Clinical study to compare efficacy and safety of Intas Ranibizumab with Lucentis in patients with Neovascular Age-Related Macular Degeneration.
  • Regularly involved in medical retina and regional ocular inflammation meetings and presentations during fellowship at Bristol Eye Hospital.
  • Dissertation: Assessment of surgical and visual outcome after keratoplasty.
  • Good Clinical Practice training: October 2016 and 2021.
Admissions Apply Now